137 related articles for article (PubMed ID: 1868237)
1. Recurrent deletion in the human antithrombin III gene.
Grundy CB; Thomas F; Millar DS; Krawczak M; Melissari E; Lindo V; Moffat E; Kakkar VV; Cooper DN
Blood; 1991 Aug; 78(4):1027-32. PubMed ID: 1868237
[TBL] [Abstract][Full Text] [Related]
2. A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Finazzi G; Barbui T; Thein SL
Blood; 1990 Dec; 76(11):2182-6. PubMed ID: 1979501
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV.
Vidaud D; Emmerich J; Sirieix ME; Sié P; Alhenc-Gelas M; Aiach M
Blood; 1991 Nov; 78(9):2305-9. PubMed ID: 1932746
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis of antithrombin type I deficiency: the first large in-frame deletion and two novel mutations in exon 6.
Emmerich J; Chadeuf G; Alhenc-Gelas M; Gouault-Heilman M; Toulon P; Fiessinger JN; Aiach M
Thromb Haemost; 1994 Oct; 72(4):534-9. PubMed ID: 7878627
[TBL] [Abstract][Full Text] [Related]
5. Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT----TGT) and antithrombin III Glasgow (393 CGT----CAT).
Thein SL; Lane DA
Blood; 1988 Nov; 72(5):1817-21. PubMed ID: 3179448
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetics of inherited antithrombin III deficiencies.
Prochownik EV
Am J Med; 1989 Sep; 87(3B):15S-18S. PubMed ID: 2572168
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.
Gandrille S; Vidaud D; Emmerich J; Clauser E; Sié P; Fiessinger JN; Alhenc-Gelas M; Priollet P; Aiach M
Br J Haematol; 1991 Jul; 78(3):414-20. PubMed ID: 1873224
[TBL] [Abstract][Full Text] [Related]
8. Hereditary thrombosis in a Utah kindred is caused by a dysfunctional antithrombin III gene.
Bock SC; Harris JF; Schwartz CE; Ward JH; Hershgold EJ; Skolnick MH
Am J Hum Genet; 1985 Jan; 37(1):32-41. PubMed ID: 2983542
[TBL] [Abstract][Full Text] [Related]
9. Novel point mutations leading to type 1 antithrombin deficiency and thrombosis.
Olds RJ; Lane DA; Ireland H; Leone G; De Stefano V; Wiesel ML; Cazenave JP; Thein SL
Br J Haematol; 1991 Jul; 78(3):408-13. PubMed ID: 1873223
[TBL] [Abstract][Full Text] [Related]
10. Partial deletion of an antithrombin III allele in a kindred with a type 1 deficiency.
Fernandez-Rachubinski F; Rachubinski RA; Blajchman MA
Blood; 1992 Sep; 80(6):1476-85. PubMed ID: 1520874
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity of inherited antithrombin III deficiency.
Prochownik EV; Antonarakis S; Bauer KA; Rosenberg RD; Fearon ER; Orkin SH
N Engl J Med; 1983 Jun; 308(26):1549-52. PubMed ID: 6304514
[TBL] [Abstract][Full Text] [Related]
12. Three novel missense mutations in the antithrombin III (AT3) gene causing recurrent venous thrombosis.
Millar DS; Wacey AI; Ribando J; Melissari E; Laursen B; Woods P; Kakkar VV; Cooper DN
Hum Genet; 1994 Nov; 94(5):509-12. PubMed ID: 7959685
[TBL] [Abstract][Full Text] [Related]
13. Identification of the antithrombin III Kyoto mutation by restriction fragment length polymorphism analysis.
Masuda H; Tsuji H; Nakagawa K; Nakahara Y; Kitamura H; Ogasahara Y; Nakagawa M
Int J Hematol; 1995 Jun; 61(4):197-204. PubMed ID: 8547608
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients.
Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H
Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013
[TBL] [Abstract][Full Text] [Related]
15. Type I antithrombin deficiency: five novel mutations associated with thrombosis.
Daly M; Perry DJ; Bruce DB; Harper PL; Tait RC; Walker ID; Mayne EE; Daly HM; Brown K; Carrell RW
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):139-43. PubMed ID: 8735803
[TBL] [Abstract][Full Text] [Related]
16. Evidence linking familial thrombosis with a defective antithrombin III gene in two British kindreds.
Sacks SH; Old JM; Reeders ST; Weatherall DJ; Douglas AS; Winter JH; Rizza CR
J Med Genet; 1988 Jan; 25(1):20-4. PubMed ID: 3162535
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic survey of 16 kindreds with hereditary antithrombin III deficiency.
Bock SC; Prochownik EV
Blood; 1987 Nov; 70(5):1273-8. PubMed ID: 3663935
[TBL] [Abstract][Full Text] [Related]
19. Antithrombin-Gly 424 Arg: a novel point mutation responsible for type 1 antithrombin deficiency and neonatal thrombosis.
Jochmans K; Lissens W; Vervoort R; Peeters S; De Waele M; Liebaers I
Blood; 1994 Jan; 83(1):146-51. PubMed ID: 8274732
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
